#hepatitis C treatment

Scientists have firmly established an association between direct-acting antiviral treatment and a lower risk of liver cancer and death.

This is according to the largest-ever analysis of the treatment cascade among people tested for hepatitis C.

Preliminary results from an ongoing trial found that half of the participants could take less than 12 weeks of a cure regimen.

In the first five months of 2018, 803 HCV-positive organs were transplanted across the United States.

Research suggests that individuals receiving opioid replacement therapy have a better chance of beating hep C through this method.

Medi-Cal will soon begin providing treatment access to almost all state-insured patients living with the virus.

Newer hep C meds may give more prisoners access to the cure.

More proof that filing treatment access lawsuits can pay off for people with HCV.

Treat hep C and strengthen your mental health.

This advocate’s call to action began with an injury, then a viral hepatitis diagnosis, then HIV.

All the major world organizations, shareholders, some countries, and the state of New York are committed to the elimination of hepatitis C.

Jailed activist and journalist Mumia Abu-Jamal sued Pennsylvania prison officials in 2015, alleging neglect over his medical condition.

The triple-drug combo would be the first once-daily, single-tablet regimen for those with all genotypes who’ve failed a previous treatment.

Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.

A regimen of standard oral drugs bookended by an injectable treatment has shown promise in curing hepatitis C in just four weeks.

Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.